Table 5. Results of multivariate survival analysis.
|
Multivariate Cox regression analysis
|
|||
|---|---|---|---|
| Hazard ratio | 95% confidence interval | P-value | |
| Progression-free survival | |||
| PTEN-negative tumour | 0.57 | 0.36–0.90 | 0.015 |
| Age>58 years | 1.09 | 0.74–1.60 | 0.671 |
| FIGO stage III/IV | 2.51 | 1.21–5.19 | 0.013 |
| Serous tumour type | 1.44 | 0.92–2.24 | 0.109 |
| Differentiation grade III/IV | 1.40 | 0.89–2.19 | 0.144 |
| Suboptimal debulking | 2.37 | 1.43–3.50 | <0.001 |
| Overall survival | |||
| PTEN-negative tumour | 0.96 | 0.62–1.47 | 0.833 |
| Age>58 years | 1.24 | 0.83–1.83 | 0.291 |
| FIGO stage III/IV | 2.56 | 1.14–5.74 | 0.023 |
| Serous tumour type | 1.46 | 0.93–2.76 | 0.100 |
| Differentiation grade III/IV | 1.50 | 0.94–2.38 | 0.090 |
| Suboptimal debulking | 2.51 | 1.57–4.00 | <0.001 |
PTEN=phosphatase and tensin homologue deleted on chromosome 10; FIGO=International Federation of Gynaecology and Obstetrics.
Bold signifies P<0.05.